{"id":2184,"date":"2023-12-13T00:00:00","date_gmt":"2023-12-13T00:00:00","guid":{"rendered":"http:\/\/centogene.vl22350.dinaserver.com\/2184"},"modified":"2023-12-13T00:00:00","modified_gmt":"2023-12-13T00:00:00","slug":"centogenes%e9%a1%8d%e9%a1%b3%e8%91%89%e5%a4%b1%e6%99%ba%e7%97%87%ef%bc%88ftd%ef%bc%89%e5%9f%ba%e5%9b%a0%e7%a0%94%e7%a9%b6efront%e9%81%94%e5%88%b0%e7%ac%ac%e4%b8%80%e6%89%b9%e7%97%85%e6%82%a3%e6%8b%9b","status":"publish","type":"post","link":"https:\/\/www.centogene.com\/tw\/centogenes-frontotemporal-dementia-ftd-genetic-study-efront-reaches-initial-patient-enrollment-milestone\/","title":{"rendered":"Centogene\u516c\u53f8\u7684\u984d\u9873\u8449\u5931\u667a\u75c7\uff08FTD\uff09\u57fa\u56e0\u7814\u7a76EFRONT\u9054\u5230\u521d\u6b65\u75c5\u60a3\u62db\u52df\u91cc\u7a0b\u7891"},"content":{"rendered":"<p><strong>\u7f8e\u570b\u9ebb\u85a9\u8af8\u585e\u5dde\u528d\u6a4b\u3001\u5fb7\u570b\u7f85\u65af\u6258\u514b\u548c\u67cf\u6797\uff0c2023\u5e7412\u670813\u65e5\uff08\u74b0\u7403\u901a\u8a0a\u793e\uff09<\/strong> \u2013 Centogene NV\uff08\u7d0d\u65af\u9054\u514b\u80a1\u7968\u4ee3\u78bc\uff1aCNTG\uff09\uff0c\u4e00\u5bb6\u5728\u7f55\u898b\u75be\u75c5\u548c\u795e\u7d93\u9000\u5316\u6027\u75be\u75c5\u9818\u57df\u63d0\u4f9b\u6578\u64da\u9a45\u52d5\u89e3\u6c7a\u65b9\u6848\u7684\u91cd\u8981\u751f\u547d\u79d1\u5b78\u5408\u4f5c\u5925\u4f34\uff0c\u4eca\u65e5\u5ba3\u4f48\u516c\u53f8\u5df2\u5728\u89c0\u5bdf\u6027\u7814\u7a76\u4e2d\u9054\u5230\u521d\u6b65\u62db\u52df\u548c\u57fa\u56e0\u6aa2\u6e2c\u91cc\u7a0b\u7891\u3002 <a href=\"t3:\/\/page?uid=3447\" title=\"EFRONT \u7814\u7a76\">EFRONT \u7814\u7a76<\/a>, \u65e8\u5728\u589e\u9032\u5c0d\u984d\u9873\u8449\u5931\u667a\u75c7\uff08FTD\uff09\u7684\u907a\u50b3\u5b78\u7406\u89e3\u3002.<\/p>\n<p>EFRONT \u7814\u7a76\u662f\u5728 Alector \u7684\u652f\u6301\u4e0b\u9032\u884c\u7684\uff0cAlector \u662f\u4e00\u5bb6\u81e8\u5e8a\u968e\u6bb5\u7684\u751f\u7269\u6280\u8853\u516c\u53f8\uff0c\u81f4\u529b\u65bc\u514d\u75ab\u795e\u7d93\u5b78\u7684\u7814\u7a76\uff0c\u9019\u662f\u4e00\u7a2e\u6cbb\u7642\u795e\u7d93\u9000\u5316\u6027\u75be\u75c5\uff08\u5305\u62ec FTD\uff09\u7684\u65b0\u7642\u6cd5\u3002.<\/p>\n<p>\u201c\u300c\u5c0d\u6f5b\u5728\u7684FTD\u81e8\u5e8a\u8a66\u9a57\u53c3\u8207\u8005\u9032\u884c\u57fa\u56e0\u8b8a\u7570\u7be9\u6aa2\u662f\u4e00\u9805\u91cd\u5927\u6311\u6230\u3002CENTOGENE\u70baFTD\u60a3\u8005\u7684\u91cd\u8981\u57fa\u56e0\u7be9\u6aa2\u63d0\u4f9b\u4e86\u652f\u6301\uff0c\u6211\u5011\u5f88\u9ad8\u8208\u80fd\u5920\u5354\u52a9\u4ed6\u5011\u9032\u884cEFRONT\u7814\u7a76\uff0c\u300dAlector\u9996\u5e2d\u91ab\u7642\u5b98Gary Romano\u91ab\u5b78\u535a\u58eb\u8868\u793a\u3002 \u201d\u984d\u9873\u8449\u5931\u667a\u75c7\u662f\u4e00\u7a2e\u6bc0\u6ec5\u6027\u75be\u75c5\uff0c\u4e9f\u9700\u65b0\u7684\u6cbb\u7642\u65b9\u6848\u3002\u57fa\u56e0\u7be9\u6aa2\u5c0d\u65bc\u5728FTD-GRN\u7b49\u57fa\u56e0\u660e\u78ba\u7684\u4eba\u7fa4\u4e2d\u6210\u529f\u958b\u5c55\u81e8\u5e8a\u8a66\u9a57\u81f3\u95dc\u91cd\u8981\u3002\u201c<\/p>\n<p>\u9054\u6210\u9019\u4e00\u91cc\u7a0b\u7891\u5f8c\uff0cCENTOGENE \u5c07\u7e7c\u7e8c\u8207\u5176\u904d\u5e03\u5168\u7403\u7684 30,000 \u540d\u91ab\u751f\u7db2\u7d61\u5408\u4f5c\uff0c\u4e26\u5728\u5176 Cento-FTD \u8a08\u756b\u4e0b\u62db\u52df\u60a3\u8005\u53c3\u8207 EFRONT \u7814\u7a76\uff0c\u4ee5\u63d0\u4f9b\u53ca\u6642\u7684\u8a3a\u65b7\u4e26\u9032\u4e00\u6b65\u6df1\u5165\u4e86\u89e3\u9019\u7a2e\u795e\u7d93\u9000\u5316\u6027\u75be\u75c5\u3002\u6211\u5011\u8aa0\u646f\u9080\u8acb\u5021\u5c0e\u5718\u9ad4\u548c\u6f5b\u5728\u5408\u4f5c\u5925\u4f34\u900f\u904e\u4ee5\u4e0b\u65b9\u5f0f\u4e86\u89e3\u66f4\u591a\u95dc\u65bc\u6b64\u8a08\u756b\u7684\u8cc7\u8a0a\uff1a <a href=\"mailto:efront@centogene.com\" title=\"\u806f\u7d61\u6211\u5011\">efront@centogene.com<\/a>. \u53c3\u52a0 EFRONT \u7814\u7a76\u4e26\u88ab\u8a3a\u65b7\u70ba\u81f4\u75c5\u7a81\u8b8a\u7684\u60a3\u8005\u53ef\u80fd\u6709\u8cc7\u683c\u53c3\u52a0\u6b63\u5728\u9032\u884c\u7684\u5e72\u9810\u6027\u81e8\u5e8a\u7814\u7a76\u3002.<\/p>\n<p>\u201c\u300c\u984d\u9873\u8449\u5931\u667a\u75c7\u662f\u4e00\u7a2e\u5feb\u901f\u9032\u5c55\u7684\u795e\u7d93\u9000\u5316\u6027\u75be\u75c5\uff0c\u8fd1\u5e74\u4f86\uff0c\u6211\u5011\u5728\u5efa\u7acb\u6700\u4f73\u8a3a\u65b7\u65b9\u6cd5\u65b9\u9762\u53d6\u5f97\u4e86\u5de8\u5927\u9032\u5c55\uff0c\u300dCENTOGENE\u57f7\u884c\u9577Kim Stratton\u8868\u793a\u3002 \u201d\u5728\u6211\u5011\u7684\u984d\u9873\u8449\u5931\u667a\u75c7\u7814\u7a76\u4e2d\u53d6\u5f97\u5982\u6b64\u95dc\u9375\u7684\u91cc\u7a0b\u7891\u5f0f\u9032\u5c55\uff0c\u4f7f\u6211\u5011\u80fd\u5920\u6df1\u5165\u4e86\u89e3\u907a\u50b3\u56e0\u7d20\u2014\u2014\u9019\u53ef\u80fd\u6709\u52a9\u65bc\u958b\u767c\u51fa\u80fd\u5920\u6539\u8b8a\u4e16\u754c\u5404\u5730\u60a3\u8005\u547d\u904b\u7684\u7642\u6cd5\u3002\u201c<\/p>\n<p>\u201c\u300c\u9019\u4e0d\u50c5\u662f\u4e00\u9805\u5de8\u5927\u7684\u6210\u5c31\uff0c\u4e5f\u9810\u793a\u8457\u672a\u4f86\u5de8\u5927\u7684\u6f5b\u529b\uff0c\u300dCENTOGENE\u516c\u53f8\u9ad8\u7d1a\u526f\u7e3d\u88c1\u517c\u771f\u5be6\u4e16\u754c\u89e3\u6c7a\u65b9\u6848\u71df\u904b\u8ca0\u8cac\u4ebaOmbretta Palucci\u88dc\u5145\u9053\u3002 \u201d\u5b83\u70ba\u5168\u7403\u6700\u5927\u7684FTD\u8a3b\u518a\u5eab\u4e4b\u4e00\u5960\u5b9a\u4e86\u57fa\u790e\uff0c\u9019\u5c07\u4f7fCento-FTD\u9805\u76ee\u73fe\u6709\u548c\u672a\u4f86\u7684\u5408\u4f5c\u5925\u4f34\u80fd\u5920\u7522\u751f\u771f\u5be6\u4e16\u754c\u8b49\u64da\uff0c\u5f9e\u800c\u6709\u53ef\u80fd\u52a0\u5feb\u6cbb\u7642\u7684\u666e\u53ca\u3002\u201c<\/p>\n<h2> \u95dc\u65bc\u984d\u9873\u8449\u5931\u667a\u75c7\uff08FTD\uff09<\/h2>\n<p>\u984d\u9873\u8449\u5931\u667a\u75c7\uff08FTD\uff09\u662f\u4e00\u7a2e\u7f55\u898b\u7684\u795e\u7d93\u9000\u5316\u6027\u75be\u75c5\uff0c\u4e5f\u662f60\u6b72\u4ee5\u4e0b\u65cf\u7fa4\u4e2d\u6700\u5e38\u898b\u7684\u5931\u667a\u75c7\u985e\u578b\u3002\u64da\u4f30\u8a08\uff0c\u7f8e\u570b\u7d04\u67095\u842c\u81f36\u842c\u4eba\u60a3\u6709\u6b64\u75c5\uff0c\u6b50\u76df\u5247\u7d04\u670911\u842c\u4eba\u3002 FTD\u6709\u591a\u7a2e\u907a\u50b3\u985e\u578b\uff0c\u5305\u62ec\u524d\u7c92\u86cb\u767d\uff08GRN\uff09\u57fa\u56e0\u7a81\u8b8a\u5f15\u8d77\u7684FTD-GRN\u3002 FTD\u60a3\u8005\u901a\u5e38\u572840\u81f350\u6b72\u6642\u51fa\u73fe\u884c\u70ba\u6539\u8b8a\u3001\u5224\u65b7\u529b\u4e0b\u964d\u53ca\u8a9e\u8a00\u80fd\u529b\u6e1b\u9000\u7b49\u75c7\u72c0\uff0c\u75c5\u7a0b\u4e00\u822c\u70ba7\u81f310\u5e74\u3002\u76ee\u524d\u5c1a\u7121\u4efb\u4f55\u4e00\u7a2eFTD\u7684FDA\u6838\u51c6\u6cbb\u7642\u65b9\u6848\u3002.<\/p>\n<h2>\u95dc\u65bc EFRONT \u7814\u7a76<\/h2>\n<p>\u9019 <a href=\"t3:\/\/page?uid=3447\" title=\"EFRONT \u7814\u7a76\">EFRONT \u7814\u7a76<\/a> \u9019\u662f\u4e00\u9805\u55ae\u6b21\u5c31\u8a3a\u3001\u591a\u4e2d\u5fc3\u3001\u975e\u5e72\u9810\u6027\u7814\u7a76\uff0c\u900f\u904e\u5c0d\u5df2\u78ba\u8a3a\u6216\u7591\u4f3c\u60a3\u6709\u984d\u9873\u8449\u5931\u667a\u75c7 (FTD) \u7684\u60a3\u8005\u9032\u884c\u57fa\u56e0\u5206\u578b\uff0c\u4f86\u8abf\u67e5 FTD \u7684\u907a\u50b3\u75c5\u56e0\u7684\u76db\u884c\u7387\u3002.<\/p>\n<p>\u984d\u9873\u8449\u5931\u667a\u75c7\uff08FTD\uff09\u662f\u4e00\u7a2e\u5177\u6709\u9ad8\u5ea6\u907a\u50b3\u7570\u8cea\u6027\u53ca\u75c5\u7406\u7570\u8cea\u6027\u7684\u795e\u7d93\u9000\u5316\u6027\u75be\u75c5\uff0c\u4e3b\u8981\u7531\u5927\u8166\u984d\u8449\u8207\u9873\u8449\u795e\u7d93\u7d30\u80de\u53d7\u640d\u6216\u6d41\u5931\u6240\u9020\u6210\u3002\n\n\u60a3\u8005\u5e38\u898b\u81e8\u5e8a\u8868\u73fe\u5305\u62ec\uff1a\n\n\u884c\u70ba\u7570\u5e38\u3001\n\u4eba\u683c\u6539\u8b8a\u3001\n\u8a9e\u8a00\u7406\u89e3\u969c\u7919\u3001\n\u8208\u8da3\u964d\u4f4e\u3001\n\u5224\u65b7\u529b\u4e0b\u964d\u3001\n\u540c\u7406\u5fc3\u55aa\u5931\u3001\n\u51b7\u6f20\uff08Apathy\uff09\u7b49\u75c7\u72c0\u3002<\/p>\n<p>\u5982\u9700\u4e86\u89e3\u66f4\u591a\u95dc\u65bc\u5982\u4f55\u53c3\u8207 EFRONT \u7814\u7a76\u7684\u4fe1\u606f\uff0c\u8acb\u8a2a\u554f <a href=\"https:\/\/clinicaltrials.gov\/study\/NCT05075187\" target=\"_blank\" title=\"\u4e86\u89e3\u66f4\u591a\">ClinicalTrials.gov<\/a>.<\/p>\n<h3> \u95dc\u65bc CENTOGENE<\/h3>\n<p>CENTOGENE \u7684\u4f7f\u547d\u662f\u70ba\u7f55\u898b\u75be\u75c5\u548c\u795e\u7d93\u9000\u5316\u6027\u75be\u75c5\u7684\u60a3\u8005\u3001\u91ab\u751f\u548c\u88fd\u85e5\u516c\u53f8\u63d0\u4f9b\u6578\u64da\u9a45\u52d5\u3001\u6539\u8b8a\u751f\u6d3b\u7684\u89e3\u6c7a\u65b9\u6848\u3002\u6211\u5011\u5c07\u591a\u7d44\u5b78\u6280\u8853\u8207 CENTOGENE \u751f\u7269\u8cc7\u6599\u5eab\u7d50\u5408\uff0c\u63d0\u4f9b\u7dad\u5ea6\u5206\u6790\uff0c\u4ee5\u6307\u5c0e\u4e0b\u4e00\u4ee3\u7cbe\u6e96\u91ab\u7642\u7684\u767c\u5c55\u3002\u6211\u5011\u7368\u7279\u7684\u65b9\u6cd5\u80fd\u5920\u70ba\u60a3\u8005\u63d0\u4f9b\u5feb\u901f\u53ef\u9760\u7684\u8a3a\u65b7\uff0c\u5e6b\u52a9\u91ab\u751f\u66f4\u7cbe\u6e96\u5730\u4e86\u89e3\u75be\u75c5\u72c0\u614b\uff0c\u4e26\u52a0\u901f\u548c\u964d\u4f4e\u6a19\u9776\u85e5\u7269\u7684\u767c\u73fe\u3001\u958b\u767c\u548c\u5546\u696d\u5316\u98a8\u96aa\u3002.<\/p>\n<p>\u81ea2006\u5e74\u6210\u7acb\u4ee5\u4f86\uff0cCENTOGENE\u4e00\u76f4\u81f4\u529b\u65bc\u63d0\u4f9b\u5feb\u901f\u53ef\u9760\u7684\u8a3a\u65b7\u670d\u52d9\uff0c\u4e26\u5df2\u5efa\u7acb\u8d77\u4e00\u500b\u7531\u7d043\u842c\u540d\u6d3b\u8e8d\u91ab\u751f\u7d44\u6210\u7684\u7db2\u8def\u3002\u6211\u5011\u5728\u5fb7\u570b\u64c1\u6709ISO\u3001CAP\u548cCLIA\u8a8d\u8b49\u7684\u591a\u7d44\u5b78\u53c3\u8003\u5be6\u9a57\u5ba4\uff0c\u9019\u4e9b\u5be6\u9a57\u5ba4\u5229\u7528\u8868\u578b\u7d44\u5b78\u3001\u57fa\u56e0\u7d44\u5b78\u3001\u8f49\u9304\u7d44\u5b78\u3001\u8868\u89c0\u57fa\u56e0\u7d44\u5b78\u3001\u86cb\u767d\u8cea\u7d44\u5b78\u548c\u4ee3\u8b1d\u7d44\u5b78\u8cc7\u6599\u96c6\u3002\u9019\u4e9b\u6578\u64da\u88ab\u6536\u96c6\u5230\u6211\u5011\u7684CENTOGENE\u751f\u7269\u8cc7\u6599\u5eab\u4e2d\uff0c\u8a72\u8cc7\u6599\u5eab\u6db5\u84cb\u4e86\u4f86\u81ea120\u591a\u500b\u4e0d\u540c\u570b\u5bb6\u548c\u5730\u5340\u768480\u591a\u842c\u540d\u60a3\u8005\uff0c\u5176\u4e2d\u8d85\u904e701\u540d\u60a3\u8005\u70ba\u975e\u6b50\u6d32\u88d4\u3002\u8fc4\u4eca\u70ba\u6b62\uff0cCENTOGENE\u751f\u7269\u8cc7\u6599\u5eab\u5df2\u70ba\u8d85\u904e285\u7bc7\u540c\u884c\u8a55\u5be9\u51fa\u7248\u7269\u63d0\u4f9b\u4e86\u65b0\u7684\u898b\u89e3\u3002.<\/p>\n<p>\u900f\u904e\u5c07\u6211\u5011\u7684\u6578\u64da\u548c\u5c08\u696d\u77e5\u8b58\u8f49\u5316\u70ba\u5207\u5be6\u53ef\u884c\u7684\u6d1e\u898b\uff0c\u6211\u5011\u5df2\u652f\u6301\u8207\u88fd\u85e5\u5408\u4f5c\u5925\u4f34\u958b\u5c55\u4e8650\u591a\u9805\u5408\u4f5c\u3002\u6211\u5011\u651c\u624b\u52a0\u901f\u4e26\u964d\u4f4e\u85e5\u7269\u767c\u73fe\u3001\u958b\u767c\u548c\u5546\u696d\u5316\u7684\u98a8\u96aa\uff0c\u6db5\u84cb\u6a19\u9776\u548c\u85e5\u7269\u7be9\u9078\u3001\u81e8\u5e8a\u958b\u767c\u3001\u5e02\u5834\u51c6\u5165\u548c\u62d3\u5c55\u7b49\u9818\u57df\uff0c\u540c\u6642\u63d0\u4f9bCENTOGENE\u751f\u7269\u6578\u64da\u8a31\u53ef\u548c\u6d1e\u5bdf\u5831\u544a\uff0c\u81f4\u529b\u65bc\u6253\u9020\u4e00\u500b\u6cbb\u6108\u6240\u6709\u7f55\u898b\u75be\u75c5\u548c\u795e\u7d93\u9000\u5316\u6027\u75be\u75c5\u7684\u4e16\u754c\u3002.<\/p>\n<p>\u5982\u6b32\u4e86\u89e3\u66f4\u591a\u95dc\u65bc\u6211\u5011\u7684\u7522\u54c1\u3001\u7814\u767c\u7ba1\u7dda\u4ee5\u53ca\u4ee5\u75c5\u4eba\u70ba\u4e2d\u5fc3\u7684\u5b97\u65e8\uff0c\u8acb\u9020\u8a2a <a href=\"https:\/\/www.centogene.com\/tw\/?ADMCMD_prev=IGNORE\" title=\"\u4e2d\u5fc3\u57fa\u56e0\">www.centogene.com<\/a>&nbsp;\u4e26\u95dc\u6ce8\u6211\u5011&nbsp;<a href=\"https:\/\/www.linkedin.com\/company\/centogene\" rel=\"noreferrer\" target=\"_blank\" title=\"LinkedIn\">LinkedIn<\/a>.<\/p>\n<h3>\u524d\u77bb\u6027\u8072\u660e<\/h3>\n<p>\u672c\u65b0\u805e\u7a3f\u5305\u542b\u7f8e\u570b\u806f\u90a6\u8b49\u5238\u6cd5\u610f\u7fa9\u4e0a\u7684\u300c\u524d\u77bb\u6027\u9673\u8ff0\u300d\u3002\u672c\u65b0\u805e\u7a3f\u4e2d\u975e\u6b77\u53f2\u4e8b\u5be6\u7684\u9673\u8ff0\u5747\u70ba\u524d\u77bb\u6027\u9673\u8ff0\uff0c\u8af8\u5982\u300c\u9810\u671f\u300d\u3001\u300c\u76f8\u4fe1\u300d\u3001\u300c\u6301\u7e8c\u300d\u3001\u300c\u671f\u671b\u300d\u3001\u300c\u4f30\u8a08\u300d\u3001\u300c\u6253\u7b97\u300d\u3001\u300c\u9810\u6e2c\u300d\u3001\u300c\u8a08\u756b\u300d\u3001\u300c\u65e8\u5728\u300d\u3001\u300c\u6f5b\u5728\u300d\u3001\u300c\u9810\u6e2c\u300d\u3001\u300c\u76ee\u6a19\u300d\u7b49\u8a5e\u8a9e\u4ee5\u53ca\u985e\u4f3c\u8868\u9054\uff0c\u9084\u6709\u8af8\u5982\u300c\u5c07\u300d\u3001\u300c\u6703\u300d\u3001\u300c\u61c9\u8a72\u5426\u5b9a\u300d\u3001\u300c\u53ef\u80fd\u8a8d\u540c\u300d\u3001\u300c\u6216\u8a31\u53ef\u4ee5\u8b58\u5225\u300d\u3001\u300c\u53ef\u80fd\u53ef\u4ee5\u8b58\u5225\u7684\u52d5\u8a5e\u300d\u3001\u300c\u6703\u300d\u3001\u300c\u61c9\u8a72\u5426\u5b9a\u300d\u3001\u300c\u9019\u4e9b\u5f62\u5f0f\u300d\u6216\u300c\u53ef\u80fd\u7684\u52d5\u8a5e\u300d\u3002\u6b64\u985e\u524d\u77bb\u6027\u9673\u8ff0\u6d89\u53ca\u5df2\u77e5\u548c\u672a\u77e5\u7684\u98a8\u96aa\u3001\u4e0d\u78ba\u5b9a\u6027\u4ee5\u53ca\u5176\u4ed6\u91cd\u8981\u56e0\u7d20\uff0c\u9019\u4e9b\u56e0\u7d20\u53ef\u80fd\u5c0e\u81f4CENTOGENE\u7684\u5be6\u969b\u696d\u7e3e\u3001\u8868\u73fe\u6216\u6210\u5c31\u8207\u524d\u77bb\u6027\u9673\u8ff0\u4e2d\u660e\u793a\u6216\u6697\u793a\u7684\u4efb\u4f55\u672a\u4f86\u696d\u7e3e\u3001\u8868\u73fe\u6216\u6210\u5c31\u5b58\u5728\u91cd\u5927\u5dee\u7570\u3002\u6b64\u985e\u98a8\u96aa\u548c\u4e0d\u78ba\u5b9a\u6027\u5305\u62ec\u4f46\u4e0d\u9650\u65bc\uff1a\u4e0d\u5229\u7684\u7d93\u6fdf\u548c\u5730\u7de3\u653f\u6cbb\u5f62\u52e2\u4ee5\u53ca\u5168\u7403\u91d1\u878d\u5e02\u5834\u7684\u4e0d\u7a69\u5b9a\u548c\u6ce2\u52d5\uff1b\u73fe\u884c\u548c\u64ec\u8b70\u7684\u6cd5\u5f8b\u3001\u6cd5\u898f\u548c\u653f\u5e9c\u653f\u7b56\u53ef\u80fd\u767c\u751f\u7684\u8b8a\u5316\uff1b\u884c\u696d\u7af6\u722d\u52a0\u5287\u548c\u6574\u5408\u5e36\u4f86\u7684\u58d3\u529b\uff1b\u76e3\u7ba1\u5be9\u6279\uff08\u5305\u62ec\u7f8e\u570b\u98df\u54c1\u85e5\u54c1\u76e3\u7763\u7ba1\u7406\u5c40\u7684\u5be9\u6279\uff09\u7684\u8cbb\u7528\u548c\u4e0d\u78ba\u5b9a\u6027\uff1b\u6211\u5011\u5c0d\u7b2c\u4e09\u65b9\u548c\u5408\u4f5c\u5925\u4f34\u7684\u4f9d\u8cf4\uff0c\u5305\u62ec\u6211\u5011\u7ba1\u7406\u589e\u9577\u3001\u57f7\u884c\u696d\u52d9\u7b56\u7565\u548c\u5efa\u7acb\u65b0\u5ba2\u6236\u95dc\u4fc2\u7684\u80fd\u529b\uff1b\u6211\u5011\u5c0d\u7f55\u898b\u75be\u75c5\u884c\u696d\u7684\u4f9d\u8cf4\uff1b\u6211\u5011\u7ba1\u7406\u570b\u969b\u64f4\u5f35\u7684\u80fd\u529b\uff1b\u6211\u5011\u5c0d\u95dc\u9375\u4eba\u54e1\u7684\u4f9d\u8cf4\uff1b\u6211\u5011\u5c0d\u77e5\u8b58\u7522\u6b0a\u4fdd\u8b77\u7684\u4f9d\u8cf4\uff1b\u532f\u7387\u5f71\u97ff\u5c0e\u81f4\u7684\u7d93\u71df\u696d\u7e3e\u6ce2\u52d5\uff1b\u6211\u5011\u7cbe\u7c21\u73fe\u91d1\u4f7f\u7528\u7684\u80fd\u529b\uff1b\u6211\u5011\u6301\u7e8c\u9075\u5b88\u8207\u91d1\u878d\u5de5\u5177\u76f8\u95dc\u7684\u5951\u7d04\uff1b\u6211\u5011\u5c0d\u984d\u5916\u878d\u8cc7\u7684\u9700\u6c42\uff1b\u4ee5\u53ca\u6211\u5011\u6301\u7e8c\u7d93\u71df\u7684\u80fd\u529b\uff0c\u6216\u5176\u4ed6\u56e0\u7d20\u3002\u6709\u95dc\u53ef\u80fd\u5c0e\u81f4\u5be6\u969b\u7d50\u679c\u8207\u9019\u4e9b\u524d\u77bb\u6027\u8072\u660e\u4e2d\u6240\u8868\u9054\u7684\u7d50\u679c\u5b58\u5728\u5dee\u7570\u7684\u98a8\u96aa\u548c\u4e0d\u78ba\u5b9a\u6027\uff0c\u4ee5\u53ca\u8207CENTOGENE\u696d\u52d9\u76f8\u95dc\u7684\u7e3d\u9ad4\u98a8\u96aa\u7684\u66f4\u591a\u4fe1\u606f\uff0c\u8acb\u53c3\u95b1CENTOGENE\u65bc2023\u5e745\u670816\u65e5\u5411\u7f8e\u570b\u8b49\u5238\u4ea4\u6613\u59d4\u54e1\u6703\uff08\u201cSEC\u201d\uff09\u63d0\u4ea4\u768420-F\u8868\u683c\u53ca\u5176\u5f8c\u7e8c\u6587\u4ef6\u4e2d\u5217\u51fa\u7684CENTOGENE\u98a8\u96aa\u56e0\u7d20\u3002\u672c\u65b0\u805e\u7a3f\u4e2d\u5305\u542b\u7684\u4efb\u4f55\u524d\u77bb\u6027\u8072\u660e\u50c5\u4ee3\u8868\u622a\u81f3\u672c\u65b0\u805e\u7a3f\u767c\u5e03\u4e4b\u65e5\u7684\u4fe1\u606f\uff0cCENTOGENE\u660e\u78ba\u8072\u660e\u4e0d\u627f\u64d4\u4efb\u4f55\u66f4\u65b0\u4efb\u4f55\u524d\u77bb\u6027\u8072\u660e\u7684\u7fa9\u52d9\uff0c\u7121\u8ad6\u662f\u56e0\u70ba\u65b0\u8cc7\u8a0a\u3001\u672a\u4f86\u4e8b\u4ef6\u6216\u5176\u4ed6\u539f\u56e0\u3002.<\/p>\n<h5>\u63a5\u89f8<\/h5>\n<p>\u4e2d\u5fc3\u57fa\u56e0&nbsp;<br \/> \u6885\u9e97\u838e\u00b7\u970d\u723e<br \/> \u4f01\u696d\u50b3\u64ad\u90e8<br \/> <a href=\"mailto:Press@centogene.com\" title=\"\u6885\u9e97\u838e\u00b7\u970d\u723e\">Press@centogene.com<\/a><\/p>\n<p>\u502b\u7d0d\u7279\u00b7\u65af\u7279\u8cf4\u8c9d\u723e<br \/> \u6295\u8cc7\u4eba\u95dc\u4fc2<br \/> <a href=\"mailto:IR@centogene.com\" title=\"\u502b\u7d0d\u7279\u00b7\u65af\u7279\u8cf4\u8c9d\u723e\">IR@centogene.com<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>Centogene NV\uff08\u7d0d\u65af\u9054\u514b\u80a1\u7968\u4ee3\u78bc\uff1aCNTG\uff09\u4eca\u5929\u5ba3\u5e03\uff0c\u8a72\u516c\u53f8\u5728\u89c0\u5bdf\u6027 EFRONT \u7814\u7a76\u4e2d\u9054\u5230\u4e86\u521d\u6b65\u62db\u52df\u548c\u57fa\u56e0\u6aa2\u6e2c\u91cc\u7a0b\u7891\uff0c\u8a72\u7814\u7a76\u65e8\u5728\u589e\u9032\u5c0d\u984d\u9873\u8449\u5931\u667a\u75c7 (FTD) \u7684\u907a\u50b3\u5b78\u7406\u89e3\u3002.<\/p>","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-2184","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>CENTOGENE\u2019s Frontotemporal Dementia (FTD) Genetic Study, EFRONT, Reaches Initial Patient Enrollment Milestone | CENTOGENE<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.centogene.com\/tw\/centogenes\u984d\u9873\u8449\u5931\u667a\u75c7\uff08ftd\uff09\u57fa\u56e0\u7814\u7a76efront\u9054\u5230\u7b2c\u4e00\u6279\u75c5\u60a3\u62db\/\" \/>\n<meta property=\"og:locale\" content=\"zh_TW\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"CENTOGENE\u2019s Frontotemporal Dementia (FTD) Genetic Study, EFRONT, Reaches Initial Patient Enrollment Milestone | CENTOGENE\" \/>\n<meta property=\"og:description\" content=\"Centogene N.V. (Nasdaq: CNTG) today announced the Company reached its initial recruitment and genetic testing milestone in the observational EFRONT Study, being conducted to advance the genetic understanding of frontotemporal dementia (FTD).\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.centogene.com\/tw\/centogenes\u984d\u9873\u8449\u5931\u667a\u75c7\uff08ftd\uff09\u57fa\u56e0\u7814\u7a76efront\u9054\u5230\u7b2c\u4e00\u6279\u75c5\u60a3\u62db\/\" \/>\n<meta property=\"og:site_name\" content=\"CENTOGENE\" \/>\n<meta property=\"article:published_time\" content=\"2023-12-13T00:00:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.centogene.com\/wp-content\/uploads\/2025\/03\/csm_centogene-diagnostics-priority-disease-03_5a57c07603.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"740\" \/>\n\t<meta property=\"og:image:height\" content=\"416\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"admincg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u4f5c\u8005:\" \/>\n\t<meta name=\"twitter:data1\" content=\"admincg\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u9810\u4f30\u95b1\u8b80\u6642\u9593\" \/>\n\t<meta name=\"twitter:data2\" content=\"6 \u5206\u9418\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/centogenes-frontotemporal-dementia-ftd-genetic-study-efront-reaches-initial-patient-enrollment-milestone\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/centogenes-frontotemporal-dementia-ftd-genetic-study-efront-reaches-initial-patient-enrollment-milestone\\\/\"},\"author\":{\"name\":\"admincg\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#\\\/schema\\\/person\\\/d9b8738539a9ddb5de5a02a909d40b8b\"},\"headline\":\"CENTOGENE\u2019s Frontotemporal Dementia (FTD) Genetic Study, EFRONT, Reaches Initial Patient Enrollment Milestone\",\"datePublished\":\"2023-12-13T00:00:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/centogenes-frontotemporal-dementia-ftd-genetic-study-efront-reaches-initial-patient-enrollment-milestone\\\/\"},\"wordCount\":1192,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#organization\"},\"articleSection\":[\"Uncategorized\"],\"inLanguage\":\"zh-TW\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.centogene.com\\\/centogenes-frontotemporal-dementia-ftd-genetic-study-efront-reaches-initial-patient-enrollment-milestone\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/centogenes-frontotemporal-dementia-ftd-genetic-study-efront-reaches-initial-patient-enrollment-milestone\\\/\",\"url\":\"https:\\\/\\\/www.centogene.com\\\/centogenes-frontotemporal-dementia-ftd-genetic-study-efront-reaches-initial-patient-enrollment-milestone\\\/\",\"name\":\"CENTOGENE\u2019s Frontotemporal Dementia (FTD) Genetic Study, EFRONT, Reaches Initial Patient Enrollment Milestone | CENTOGENE\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#website\"},\"datePublished\":\"2023-12-13T00:00:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/centogenes-frontotemporal-dementia-ftd-genetic-study-efront-reaches-initial-patient-enrollment-milestone\\\/#breadcrumb\"},\"inLanguage\":\"zh-TW\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.centogene.com\\\/centogenes-frontotemporal-dementia-ftd-genetic-study-efront-reaches-initial-patient-enrollment-milestone\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/centogenes-frontotemporal-dementia-ftd-genetic-study-efront-reaches-initial-patient-enrollment-milestone\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.centogene.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"CENTOGENE\u2019s Frontotemporal Dementia (FTD) Genetic Study, EFRONT, Reaches Initial Patient Enrollment Milestone\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#website\",\"url\":\"https:\\\/\\\/www.centogene.com\\\/\",\"name\":\"CENTOGENE\",\"description\":\"Guiding Precision Medicine\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.centogene.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"zh-TW\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#organization\",\"name\":\"CENTOGENE\",\"url\":\"https:\\\/\\\/www.centogene.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-TW\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.centogene.com\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/CENTOGENE-Flower.png\",\"contentUrl\":\"https:\\\/\\\/www.centogene.com\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/CENTOGENE-Flower.png\",\"width\":246,\"height\":246,\"caption\":\"CENTOGENE\"},\"image\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.linkedin.com\\\/company\\\/centogene\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UClZxtN_laC1_ZtCdxkasdPQ\",\"https:\\\/\\\/www.instagram.com\\\/_centogene_\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#\\\/schema\\\/person\\\/d9b8738539a9ddb5de5a02a909d40b8b\",\"name\":\"admincg\",\"url\":\"https:\\\/\\\/www.centogene.com\\\/tw\\\/author\\\/admincg\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"CENTOGENE \u7684\u984d\u9873\u8449\u5931\u667a\u75c7 (FTD) \u57fa\u56e0\u7814\u7a76 EFRONT \u9054\u5230\u9996\u6279\u75c5\u60a3\u62db\u52df\u91cc\u7a0b\u7891 | CENTOGENE","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.centogene.com\/tw\/centogenes\u984d\u9873\u8449\u5931\u667a\u75c7\uff08ftd\uff09\u57fa\u56e0\u7814\u7a76efront\u9054\u5230\u7b2c\u4e00\u6279\u75c5\u60a3\u62db\/","og_locale":"zh_TW","og_type":"article","og_title":"CENTOGENE\u2019s Frontotemporal Dementia (FTD) Genetic Study, EFRONT, Reaches Initial Patient Enrollment Milestone | CENTOGENE","og_description":"Centogene N.V. (Nasdaq: CNTG) today announced the Company reached its initial recruitment and genetic testing milestone in the observational EFRONT Study, being conducted to advance the genetic understanding of frontotemporal dementia (FTD).","og_url":"https:\/\/www.centogene.com\/tw\/centogenes\u984d\u9873\u8449\u5931\u667a\u75c7\uff08ftd\uff09\u57fa\u56e0\u7814\u7a76efront\u9054\u5230\u7b2c\u4e00\u6279\u75c5\u60a3\u62db\/","og_site_name":"CENTOGENE","article_published_time":"2023-12-13T00:00:00+00:00","og_image":[{"width":740,"height":416,"url":"https:\/\/www.centogene.com\/wp-content\/uploads\/2025\/03\/csm_centogene-diagnostics-priority-disease-03_5a57c07603.webp","type":"image\/webp"}],"author":"admincg","twitter_card":"summary_large_image","twitter_misc":{"\u4f5c\u8005:":"admincg","\u9810\u4f30\u95b1\u8b80\u6642\u9593":"6 \u5206\u9418"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.centogene.com\/centogenes-frontotemporal-dementia-ftd-genetic-study-efront-reaches-initial-patient-enrollment-milestone\/#article","isPartOf":{"@id":"https:\/\/www.centogene.com\/centogenes-frontotemporal-dementia-ftd-genetic-study-efront-reaches-initial-patient-enrollment-milestone\/"},"author":{"name":"admincg","@id":"https:\/\/www.centogene.com\/#\/schema\/person\/d9b8738539a9ddb5de5a02a909d40b8b"},"headline":"CENTOGENE\u2019s Frontotemporal Dementia (FTD) Genetic Study, EFRONT, Reaches Initial Patient Enrollment Milestone","datePublished":"2023-12-13T00:00:00+00:00","mainEntityOfPage":{"@id":"https:\/\/www.centogene.com\/centogenes-frontotemporal-dementia-ftd-genetic-study-efront-reaches-initial-patient-enrollment-milestone\/"},"wordCount":1192,"commentCount":0,"publisher":{"@id":"https:\/\/www.centogene.com\/#organization"},"articleSection":["Uncategorized"],"inLanguage":"zh-TW","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.centogene.com\/centogenes-frontotemporal-dementia-ftd-genetic-study-efront-reaches-initial-patient-enrollment-milestone\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.centogene.com\/centogenes-frontotemporal-dementia-ftd-genetic-study-efront-reaches-initial-patient-enrollment-milestone\/","url":"https:\/\/www.centogene.com\/centogenes-frontotemporal-dementia-ftd-genetic-study-efront-reaches-initial-patient-enrollment-milestone\/","name":"CENTOGENE \u7684\u984d\u9873\u8449\u5931\u667a\u75c7 (FTD) \u57fa\u56e0\u7814\u7a76 EFRONT \u9054\u5230\u9996\u6279\u75c5\u60a3\u62db\u52df\u91cc\u7a0b\u7891 | CENTOGENE","isPartOf":{"@id":"https:\/\/www.centogene.com\/#website"},"datePublished":"2023-12-13T00:00:00+00:00","breadcrumb":{"@id":"https:\/\/www.centogene.com\/centogenes-frontotemporal-dementia-ftd-genetic-study-efront-reaches-initial-patient-enrollment-milestone\/#breadcrumb"},"inLanguage":"zh-TW","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.centogene.com\/centogenes-frontotemporal-dementia-ftd-genetic-study-efront-reaches-initial-patient-enrollment-milestone\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.centogene.com\/centogenes-frontotemporal-dementia-ftd-genetic-study-efront-reaches-initial-patient-enrollment-milestone\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.centogene.com\/"},{"@type":"ListItem","position":2,"name":"CENTOGENE\u2019s Frontotemporal Dementia (FTD) Genetic Study, EFRONT, Reaches Initial Patient Enrollment Milestone"}]},{"@type":"WebSite","@id":"https:\/\/www.centogene.com\/#website","url":"https:\/\/www.centogene.com\/","name":"\u4e2d\u5fc3\u57fa\u56e0","description":"\u5f15\u9818\u7cbe\u6e96\u91ab\u7642","publisher":{"@id":"https:\/\/www.centogene.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.centogene.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"zh-TW"},{"@type":"Organization","@id":"https:\/\/www.centogene.com\/#organization","name":"\u4e2d\u5fc3\u57fa\u56e0","url":"https:\/\/www.centogene.com\/","logo":{"@type":"ImageObject","inLanguage":"zh-TW","@id":"https:\/\/www.centogene.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.centogene.com\/wp-content\/uploads\/2026\/04\/CENTOGENE-Flower.png","contentUrl":"https:\/\/www.centogene.com\/wp-content\/uploads\/2026\/04\/CENTOGENE-Flower.png","width":246,"height":246,"caption":"CENTOGENE"},"image":{"@id":"https:\/\/www.centogene.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/centogene","https:\/\/www.youtube.com\/channel\/UClZxtN_laC1_ZtCdxkasdPQ","https:\/\/www.instagram.com\/_centogene_\/"]},{"@type":"Person","@id":"https:\/\/www.centogene.com\/#\/schema\/person\/d9b8738539a9ddb5de5a02a909d40b8b","name":"\u7ba1\u7406\u54e1","url":"https:\/\/www.centogene.com\/tw\/author\/admincg\/"}]}},"_links":{"self":[{"href":"https:\/\/www.centogene.com\/tw\/wp-json\/wp\/v2\/posts\/2184","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.centogene.com\/tw\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.centogene.com\/tw\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.centogene.com\/tw\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.centogene.com\/tw\/wp-json\/wp\/v2\/comments?post=2184"}],"version-history":[{"count":0,"href":"https:\/\/www.centogene.com\/tw\/wp-json\/wp\/v2\/posts\/2184\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.centogene.com\/tw\/wp-json\/wp\/v2\/media?parent=2184"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.centogene.com\/tw\/wp-json\/wp\/v2\/categories?post=2184"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.centogene.com\/tw\/wp-json\/wp\/v2\/tags?post=2184"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}